Skip to main content
. 2018 Oct;13(4):166–172.

Table 2.

Characteristics of the patients with successful ECMO*

Total Unsuccessful
(n=11)
Successful
(n=37)
P
Age (y) 35.03±16.61 39.61±15.94 33.64±16.82 0.303
Male 33 (68.8) 7 (63.6) 26 (70.3) 0.720
Duration of ECMO (hr) 29 (22-72) 24 (22-72) 34 (21-72) 0.812
Alive at discharge 17 (35.4) 0 17 (45.9) 0.004
Cause of ECMO 0.025
        AIDS 1 (2.1) 1 (9.1) 0
        H1N1 influenza 2 (4.2) 1 (9.1) 1 (2.7)
        Post cardiotomy 3 (6.3) 0 3 (8.1)
        Heart transplantation 3 (6.3) 1 (9.1) 2 (5.4)
        Alveolar proteinosis 4 (8.3) 0 4 (10.8)
        Lung transplantation 24 (50.0) 3 (27.3) 21 (56.8)
        Pulmonary embolectomy 1 (2.1) 1 (9.1) 0
        Pulmonary endarterectomy 3 (6.3) 0 3 (8.1)
        ARDS 6 (12.5) 4 (36.4) 2 (5.4)
        Carinal tumor 1 (2.1) 0 1 (2.7)
Failed organs 0.113
        Heart failure 6 (12.5) 1 (9.1) 5 (13.5)
        Lung failure 37 (77.1) 7 (63.6) 30 (81.1)
        Sepsis (Heart and Lung failure) 5 (10.4) 3 (27.3) 2 (5.4)
Cause of death 0.006
        Asphyxia 1 (3.2) 1 (9.1) 0
        Bleeding 4 (12.9) 1 (9.1) 3 (15.0)
        CVA 1 (3.2) 0 1 (5.0)
        MSOF 8 (25.8) 7 (63.6) 1 (5.0)
        Rejection 1 (3.2) 0 1 (5.0)
        Sepsis 16 (51.6) 2 (18.2) 14 (70.0)

The significance of the differences between the groups was assessed with a t-test for age, a Mann–Whitney test for the duration of ECMO, and a Fisher exact test for all the other variables.

ECMO, Extracorporeal membrane oxygenation; ARDS, Adult respiratory distress syndrome; CVA, Cerebrovascular accidents; MSOF, Multisystem organ failure

*

Data are presented as mean±SD for age, as median (25–75%) for the duration of ECMO, and as number (%) for all the other variables.